Publication of Amoéba's 2026 half-year financial report

Amoéba, a greentech company specializing in microbiological solutions, has announced the availability of its half-year financial report ending June 30, 2026. The report can be viewed on the company's website. The financial statements, approved by the Board of Directors on October 29 and reviewed without reservation by the auditors, remain unchanged from the provisional financial statements dated September 24, 2026.

Based in Chassieu, Amoéba focuses on the global biocontrol market for plant protection and the cosmetics industry, where it uses the Willaertia amoeba. Amoéba has obtained approvals in the United States and Europe for its products, such as AXPERA. The company is listed on Euronext Growth and is eligible for the French PEA-PME investment scheme.